First Tracks Biotherapeutics TRAX
NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

First Tracks Biotherapeutics (TRAX) EPS (Diluted) (2025 - 2026)

Updated

First Tracks Biotherapeutics' EPS (Diluted) came in at -$0.88 for Q3 2026, compared with -$1.50 a year earlier.

Analysis

First Tracks Biotherapeutics (TRAX) EPS (Diluted) (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, First Tracks Biotherapeutics reported EPS (Diluted) of -$7.87; for FY2025, it was -$5.97.

  • Business Quant data shows TRAX's EPS (Diluted) at -$0.95 (Q2 2026), -$1.81 (Q1 2026) and -$5.97 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 7.22
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 0.09
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.38
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.04
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 2.00
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 7.08
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.94
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 0.56
10 First Tracks Biotherapeutics 1.66 Bn 740.14 Mn - -0.88
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -0.88
Jun 30, 2026 -0.95
Mar 31, 2026 -1.81
Dec 31, 2025 -5.97
Sep 30, 2025 -1.50
Jun 30, 2025 -1.47
API Access

First Tracks Biotherapeutics EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=TRAX&period=max&api_key=YOUR_API_KEY